Biopharma

BiaCure Therapies – Redefining Healthcare Standards

BiaCureâ„¢ Therapies Redefining Healthcare Standards: The Wisconsin Leaders Bringing Breakthrough Medical Solutions to Life. Innovation isn’t just about discovering new technologies—it’s about assembling the right team of experts to solve the most pressing unmet clinical needs. This belief has fueled every venture led by Laura King. BiaCure is more than just another startup. It is […]

BiaCure Therapies – Redefining Healthcare Standards Read More »

Arzeda.

SOLVING TODAY’S HARDEST CHALLENGES THROUGH INTELLIGENT PROTEIN DESIGN It’s no secret that the future of more sustainable products is already being driven by cutting-edge technology and groundbreaking innovation. Among the leaders defining this future is Seattle-based industry-leading Protein Design Company, Arzeda. Recognizing the vast potential and opportunity to transform the way products are made, co-founders

Arzeda. Read More »

SYRIDEX-BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS

BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS. Princeton-based Syridex Bio is a biopharma investment firm that makes early-stage, venture creation investments in innovative treatments that can bring transformative changes to diseases disproportionately affecting underserved communities. It is uniquely focused on double bottom-line returns, delivering compelling

SYRIDEX-BIOPHARMA INVESTMENT FIRM SYRIDEX BIO ADDRESSES HEALTH EQUITY BY FUNDING R&D OF THERAPIES DISPROPORTIONATELY AFFECTING UNDERSERVED POPULATIONS Read More »